169 related articles for article (PubMed ID: 32816995)
1. Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications.
Birukov A; Eichelmann F; Kuxhaus O; Polemiti E; Fritsche A; Wirth J; Boeing H; Weikert C; Schulze MB
Diabetes Care; 2020 Dec; 43(12):2930-2937. PubMed ID: 32816995
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Price AH; Welsh P; Weir CJ; Feinkohl I; Robertson CM; Morling JR; McLachlan S; Strachan MW; Sattar N; Price JF
Diabetologia; 2014 Dec; 57(12):2505-12. PubMed ID: 25231020
[TBL] [Abstract][Full Text] [Related]
3. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
Hamano K; Nakadaira I; Suzuki J; Gonai M
Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
[TBL] [Abstract][Full Text] [Related]
4. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.
Fraty M; Velho G; Gand E; Fumeron F; Ragot S; Sosner P; Mohammedi K; Gellen B; Saulnier PJ; Halimi JM; Montaigne D; Ducrocq G; Rehman M; Marre M; Roussel R; Hadjadj S;
Diabetologia; 2018 Dec; 61(12):2643-2653. PubMed ID: 30232509
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
Rørth R; Jhund PS; Kristensen SL; Desai AS; Køber L; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Eur J Heart Fail; 2019 Jan; 21(1):40-49. PubMed ID: 30537261
[TBL] [Abstract][Full Text] [Related]
7. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
Grauslund J; Nybo M; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
[TBL] [Abstract][Full Text] [Related]
9. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
10. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
11. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
12. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
13. Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
Welsh P; Woodward M; Hillis GS; Li Q; Marre M; Williams B; Poulter N; Ryan L; Harrap S; Patel A; Chalmers J; Sattar N
Diabetes Care; 2014 Aug; 37(8):2202-10. PubMed ID: 24879844
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.
Malachias MVB; Jhund PS; Claggett BL; Wijkman MO; Bentley-Lewis R; Chaturvedi N; Desai AS; Haffner SM; Parving HH; Prescott MF; Solomon SD; De Zeeuw D; McMurray JJV; Pfeffer MA
J Am Heart Assoc; 2020 Oct; 9(19):e017462. PubMed ID: 32964800
[TBL] [Abstract][Full Text] [Related]
15. Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.
Wirth J; Buijsse B; di Giuseppe R; Fritsche A; Hense HW; Westphal S; Isermann B; Boeing H; Weikert C
PLoS One; 2014; 9(11):e113710. PubMed ID: 25423197
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications.
Beer S; Golay S; Bardy D; Feihl F; Gaillard RC; Bachmann C; Waeber B; Ruiz J
Diabetes Metab; 2005 Dec; 31(6):567-73. PubMed ID: 16357805
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women.
Everett BM; Cook NR; Chasman DI; Magnone MC; Bobadilla M; Rifai N; Ridker PM; Pradhan AD
Clin Chem; 2013 Mar; 59(3):557-65. PubMed ID: 23288489
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
20. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
